Sigrid S Skånland

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Venues

Science (New York, N.Y.)

Clinical cancer research : an official journal of the American Association for Cancer Research

NPJ precision oncology

Cell death discovery

Oslo University Hospital and University of Oslo

University of Oslo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oslo University Hospital and University of Oslo

Norway

Senior Researcher and Lab Leader :: Institute for Cancer Research, Department of Cancer Immunology

University of Oslo

Norway

Lab Leader :: Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership

University of Oslo

Norway

Senior Researcher :: Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership

University of Oslo

Norway

PostDoc :: Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership

Goethe University School of Medicine

Germany

EMBO fellow :: Institute of Biochemistry II

Education History

University of Oslo

Norway

PHD :: The Norwegian Radium Hospital

University of Oslo

Norway

MSC :: The Norwegian Radium Hospital

Publications

Sigrid S Skånland, Klaus Okkenhaug, Matthew S Davids
PI3K Inhibitors in Hematology: When One Door Closes…. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Johanne U Hermansen, Yanping Yin, Idun Dale Rein, Sigrid S Skånland
Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery. NPJ precision oncology 8 (1) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Johanne U Hermansen, Yanping Yin, Idun Dale Rein, Sigrid S Skånland
Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery. NPJ precision oncology 8 (1) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Johanne U Hermansen, Yanping Yin, Idun Dale Rein, Sigrid S Skånland
Immunophenotyping with (phospho)protein profiling and fluorescent cell barcoding for single-cell signaling analysis and biomarker discovery. NPJ precision oncology 8 (1) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Skye Montoya, Jessie Bourcier, Mark Noviski, Hao Lu, Meghan C Thompson, Alexandra Chirino, Thomas Jacob Jahn, Anya K Sondhi, Stefan Gajewski, Ying Siow May Tan, Stephanie Yung, Aleksandra Urban, Eric Wang, Cuijuan Han, Xiaoli Mi, Won Jun Kim, Quinlan L Sievers, Paul Auger, Hugo Bousquet, Nivetha Brathaban, Brandon Bravo, Melissa Gessner, Cristiana Guiducci, James N Iuliano, Tim Kane, Ratul Mukerji, Panga Jaipal Reddy, Janine Powers, Mateo Sanchez Garcia de Los Rios, Jordan Ye, Carla Barrientos Risso, Daniel Tsai, Gabriel Pardo, Ryan Q Notti, Alejandro Pardo, Maurizio Affer, Vindhya Nawaratne, Tulasigeri M Totiger, Camila Pena-Velasquez, Joanna M Rhodes, Andrew D Zelenetz, Alvaro Alencar, Lindsey Elizabeth Roeker, Sanjoy Mehta, Ralph Garippa, Adam J Linley, Rajesh Kumar Soni, Sigrid S Skånland, Robert J Brown, Anthony R Mato, Gwenn H Hansen, Omar Abdel-Wahab, Justin Taylor
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127. Science (New York, N.Y.) 383 (6682) (2024)
Sigrid S Skånland, Klaus Okkenhaug, Matthew S Davids
PI3K inhibitors in hematology: When one door closes…. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Johanne U Hermansen, Yanping Yin, Aleksandra Urban, Camilla V Myklebust, Linda Karlsen, Katrine Melvold, Anders A Tveita, Kjetil Taskén, Ludvig A Munthe, Geir Erland Tjønnfjord, Sigrid S Skånland
A tumor microenvironment model of chronic lymphocytic leukemia enables drug sensitivity testing to guide precision medicine. Cell death discovery 9 (1) (2023)
Pilar Ayuda-Durán, Johanne U Hermansen, Mariaserena Giliberto, Yanping Yin, Robert Hanes, Sandra L Gordon, Heikki Kuusanmäki, Andrea M Brodersen, Aram N Andersen, Kjetil Taskén, Krister Wennerberg, Jorrit M Enserink, Sigrid S Skånland
Standardized assays to monitor drug sensitivity in hematologic cancers. Cell death discovery 9 (1) (2023)
Yanping Yin, Paschalis Athanasiadis, Linda Karlsen, Aleksandra Urban, Haifeng Xu, Ishwarya Murali, Stacey M Fernandes, Alberto J Arribas, Abdul K Hilli, Kjetil Taskén, Francesco Bertoni, Anthony R Mato, Emmanuel Normant, Jennifer R Brown, Geir Erland Tjønnfjord, Tero Aittokallio, Sigrid S Skånland
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Mariaserena Giliberto, Deepak B Thimiri Govinda Raj, Andrea Cremaschi, Sigrid S Skånland, Alexandra Gade, Geir E Tjønnfjord, Fredrik Schjesvold, Ludvig A Munthe, Kjetil Taskén
Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically. Molecular oncology 16 (6) (2022)
Sigrid S Skånland, Geir Erland Tjønnfjord
Determining drug dose in the era of targeted therapies: playing it (un)safe? Blood cancer journal 12 (8) (2022)
Xiaojun Jiang, Annika Bergquist, Britt-Sabina Petersen, Geetha Venkatesh, Jeff E Mold, Kristian Holm, Jon Kristen Laerdahl, Sigrid S Skånland, Kimia T Maleki, Martin Cornillet Jeannin, Kjetil Taskén, Andre Franke, Tom H Karlsen, Niklas K Björkström, Espen Melum
A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis. Science translational medicine 13 (582) (2021)
Sigrid S Skånland, Linda Karlsen, Kjetil Taskén
B cell signalling pathways-New targets for precision medicine in chronic lymphocytic leukaemia. Scandinavian journal of immunology 92 (5) (2020)
Sigrid S Skånland, Andrea Cremaschi, Henrik Bendiksen, Johanne U Hermansen, Deepak B Thimiri Govinda Raj, Ludvig A Munthe, Geir E Tjønnfjord, Kjetil Taskén
An in vitro assay for biomarker discovery and dose prediction applied to ibrutinib plus venetoclax treatment of CLL. Leukemia 34 (2) (2019)
Sigrid S Skånland, Kjetil Taskén
Carboxyl-Terminal Src Kinase Binds CD28 upon Activation and Mutes Downstream Signaling. Journal of immunology (Baltimore, Md. : 1950) 203 (4) (2019)

Sigrid S Skånland.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sigrid S Skånland